Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Valdecoxib
Drug ID BADD_D02325
Description Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about a possible increased risk of heart attack and stroke.
Indications and Usage For the treatment of osteoarthritis and dysmenorrhoea
Marketing Status approved; investigational; withdrawn
ATC Code M01AH03
DrugBank ID DB00580
KEGG ID D02709
MeSH ID C406224
PubChem ID 119607
TTD Drug ID D0L6DA
NDC Product Code Not Available
UNII 2919279Q3W
Synonyms valdecoxib | Bextra | SC 65872 | SC-65872
Chemical Information
Molecular Formula C16H14N2O3S
CAS Registry Number 181695-72-7
SMILES CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Emphysema22.01.02.002---
Enterocolitis haemorrhagic07.08.01.007; 24.07.02.006---
Eosinophilia01.02.04.001--
Epistaxis22.04.03.001; 24.07.01.005--
Eructation07.01.02.003--
Erythema multiforme10.01.03.015; 23.03.01.003--
Eye pain06.08.03.002--
Eye swelling06.08.03.003---
Face oedema08.01.07.003; 10.01.05.002; 23.04.01.004--
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014---
Flatulence07.01.04.002--
Fluid retention14.05.06.002; 20.01.02.003---
Fracture12.04.02.001; 15.08.02.001--
Frequent bowel movements07.02.04.002---
Fungal infection11.03.05.001---
Fungal skin infection11.03.05.002; 23.11.03.006---
Gastric cancer07.21.02.001; 16.13.03.001---
Gastric ulcer07.04.03.002--
Gastritis07.08.02.001--
Gastrooesophageal reflux disease07.02.02.003--
Gastroenteritis07.19.03.001; 11.01.07.004---
Gastrointestinal haemorrhage07.12.02.001; 24.07.02.009---
Gastrointestinal pain07.01.05.005--
Generalised oedema08.01.07.004; 14.05.06.007--
Genital candidiasis11.03.03.002; 21.10.03.001---
Glycosuria20.02.01.005--
Goitre05.02.01.001; 14.11.01.008---
Gout14.09.01.001; 15.01.06.001---
Haemangioma16.02.01.002; 24.03.06.004---
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 10 Pages